268 related articles for article (PubMed ID: 32104669)
1. The Immune Modulation Effect of Locoregional Therapies and Its Potential Synergy with Immunotherapy in Hepatocellular Carcinoma.
Singh P; Toom S; Avula A; Kumar V; Rahma OE
J Hepatocell Carcinoma; 2020; 7():11-17. PubMed ID: 32104669
[TBL] [Abstract][Full Text] [Related]
2. Interventional Radiology Image-Guided Locoregional Therapies (LRTs) and Immunotherapy for the Treatment of HCC.
Biondetti P; Saggiante L; Ierardi AM; Iavarone M; Sangiovanni A; Pesapane F; Fumarola EM; Lampertico P; Carrafiello G
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830949
[TBL] [Abstract][Full Text] [Related]
3. The immune response of hepatocellular carcinoma after locoregional and systemic therapies: The available combination option for immunotherapy.
Duan Y; Zhang H; Tan T; Ye W; Yin K; Yu Y; Kang M; Yang J; Liao R
Biosci Trends; 2024 Jan; 17(6):427-444. PubMed ID: 37981319
[TBL] [Abstract][Full Text] [Related]
4. Immune Responses Following Locoregional Treatment for Hepatocellular Carcinoma: Possible Roles of Adjuvant Immunotherapy.
Han JW; Yoon SK
Pharmaceutics; 2021 Sep; 13(9):. PubMed ID: 34575463
[TBL] [Abstract][Full Text] [Related]
5. Locoregional therapies for hepatocellular carcinoma: The current status and future perspectives.
Chen JJ; Jin ZC; Zhong BY; Fan W; Zhang WH; Luo B; Wang YQ; Teng GJ; Zhu HD
United European Gastroenterol J; 2024 Mar; 12(2):226-239. PubMed ID: 38372444
[TBL] [Abstract][Full Text] [Related]
6. Advances in locoregional therapy for hepatocellular carcinoma combined with immunotherapy and targeted therapy.
Xue J; Ni H; Wang F; Xu K; Niu M
J Interv Med; 2021 Aug; 4(3):105-113. PubMed ID: 34805958
[TBL] [Abstract][Full Text] [Related]
7. New insights into mechanisms and interventions of locoregional therapies for hepatocellular carcinoma.
Liu H; Wang C; Wang R; Cao H; Cao Y; Huang T; Lu Z; Xiao H; Hu M; Wang H; Zhao J
Chin J Cancer Res; 2024 Apr; 36(2):167-194. PubMed ID: 38751435
[TBL] [Abstract][Full Text] [Related]
8. Locoregional Therapy, Immunotherapy and the Combination in Hepatocellular Carcinoma: Future Directions.
Dendy MS; Ludwig JM; Stein SM; Kim HS
Liver Cancer; 2019 Oct; 8(5):326-340. PubMed ID: 31768343
[TBL] [Abstract][Full Text] [Related]
9. Radiofrequency ablation for hepatocellular carcinoma induces glypican-3 peptide-specific cytotoxic T lymphocytes.
Nobuoka D; Motomura Y; Shirakawa H; Yoshikawa T; Kuronuma T; Takahashi M; Nakachi K; Ishii H; Furuse J; Gotohda N; Takahashi S; Nakagohri T; Konishi M; Kinoshita T; Komori H; Baba H; Fujiwara T; Nakatsura T
Int J Oncol; 2012 Jan; 40(1):63-70. PubMed ID: 21922136
[TBL] [Abstract][Full Text] [Related]
10. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective.
Poon RT; Fan ST; Tsang FH; Wong J
Ann Surg; 2002 Apr; 235(4):466-86. PubMed ID: 11923602
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy Plus Locoregional Therapy Leading to Curative-Intent Hepatectomy in HCC: Proof of Concept Producing Durable Survival Benefits Detectable with Liquid Biopsy.
Raj R; Wehrle CJ; Aykun N; Stitzel H; Ma WW; Krishnamurthi S; Estfan B; Kamath S; Kwon DCH; Aucejo F
Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958394
[TBL] [Abstract][Full Text] [Related]
12. Transarterial chemoembolization for hepatocellular carcinoma: A review of techniques.
Imai N; Ishigami M; Ishizu Y; Kuzuya T; Honda T; Hayashi K; Hirooka Y; Goto H
World J Hepatol; 2014 Dec; 6(12):844-50. PubMed ID: 25544871
[TBL] [Abstract][Full Text] [Related]
13. Post Locoregional Therapy Treatment Imaging in Hepatocellular Carcinoma Patients: A Literature-based Review.
Young S; Taylor AJ; Sanghvi T
J Clin Transl Hepatol; 2018 Jun; 6(2):189-197. PubMed ID: 29951364
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy for hepatocellular carcinoma following thermal ablation.
Li X; Liang P
J BUON; 2014; 19(4):867-71. PubMed ID: 25536588
[TBL] [Abstract][Full Text] [Related]
15. Locoregional Therapy Approaches for Hepatocellular Carcinoma: Recent Advances and Management Strategies.
Makary MS; Khandpur U; Cloyd JM; Mumtaz K; Dowell JD
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32679897
[TBL] [Abstract][Full Text] [Related]
16. Radiological biomarkers for assessing response to locoregional therapies in hepatocellular carcinoma: From morphological to functional imaging (Review).
Ye XD; Yuan Z; Zhang J; Yuan Z
Oncol Rep; 2017 Mar; 37(3):1337-1346. PubMed ID: 28184942
[TBL] [Abstract][Full Text] [Related]
17. Pre- and post- operative adjuvant targeting locoregional chemotherapy combined with locoregional targeting immunostimulation and surgical resection for hepatocellular carcinoma. A new promising alternative.
Lygidakis NJ; Konstantinidou T; Pothoulakis J
Anticancer Res; 1994; 14(3B):1351-5. PubMed ID: 8067704
[TBL] [Abstract][Full Text] [Related]
18. Contemporary Systematic Review of Health-Related Quality of Life Outcomes in Locoregional Therapies for Hepatocellular Carcinoma.
Das A; Gabr A; O'Brian DP; Riaz A; Desai K; Thornburg B; Kallini JR; Mouli S; Lewandowski RJ; Salem R
J Vasc Interv Radiol; 2019 Dec; 30(12):1924-1933.e2. PubMed ID: 31685362
[TBL] [Abstract][Full Text] [Related]
19. Radiologic-histological correlation of hepatocellular carcinoma treated via pre-liver transplant locoregional therapies.
El-Gazzaz G; Sourianarayanane A; Menon KV; Sanabria J; Hashimoto K; Quintini C; Kelly D; Eghtesad B; Miller C; Fung J; Aucejo F
Hepatobiliary Pancreat Dis Int; 2013 Feb; 12(1):34-41. PubMed ID: 23392796
[TBL] [Abstract][Full Text] [Related]
20. Locoregional Therapies in the Treatment of 3- to 5-cm Hepatocellular Carcinoma: Critical Review of the Literature.
Young S; Golzarian J
AJR Am J Roentgenol; 2020 Jul; 215(1):223-234. PubMed ID: 32255691
[No Abstract] [Full Text] [Related]
[Next] [New Search]
